Urabe, Ayako
Imamura, Michio
Tsuge, Masataka
Kan, Hiromi
Fujino, Hatsue
Fukuhara, Takayuki
Masaki, Keiichi
Kobayashi, Tomoki
Ono, Atsushi
Nakahara, Takashi
Kawaoka, Tomokazu
Hiramatsu, Akira
Kawakami, Yoshiiku
Aikata, Hiroshi
Hayes, Clair Nelson
Maki, Noboru
Ohdan, Hideaki
Chayama, Kazuaki
Funding for this research was provided by:
AMED (15fk0210001h0002)
Article History
Received: 27 December 2015
Accepted: 2 July 2016
First Online: 15 July 2016
Compliance with ethical standards
:
: Kazuaki Chayama received honoraria from MSD K.K., Bristol-Meyers Squibb, Gilead Sciences, and AbbVie; and research funding from Dainippon Sumitomo Pharma, TORAY, Eisai, Otsuka Pharma, Mitsubishi Tanabe Pharma, Daiichi Sankyo, and Bristol-Meyers Squibb. Michio Imamura received honoraria and research funding from Bristol-Meyers Squibb. Masataka Tsuge received research funding from Bristol-Meyers Squibb.
: This research is partially supported by research funding from the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED (Grant Number: 15fk0210001h0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.